Home Antibody All anti-BIRC7 antibodies
Also for BIRC7 (NM_022161)
|Livin antibody was raised with a synthetic peptide corresponding to amino acids 264 to 280 of the short form and 281 to 298 of the long form of human Livin (1,3) This sequence is identical between a and b forms of the Livin proteins .|
||WB: 2 - 4 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens baculoviral IAP repeat containing 7 (BIRC7), transcript variant 2|
|KIAP; LIVIN; ML-IAP; MLIAP; RNF50|
|Apoptosis, or programmed cell death, is related to many diseases, such as cancer. Apoptosis is triggered by a variety of stimuli including members in the TNF family and prevented by the inhibitor of apoptosis (IAP) proteins. IAP proteins form a conserved gene family that binds to and inhibits cell death proteases. A novel member in the IAP protein family was recently identified and designated Livin and KIAP for kidney IAP (1,2). Livin/XIAP contains a single baculoviral IAP repeat (BIR) domain and a RING finger domain and has two isoforms termed Livin-a and Livin-b (1,3). Transfection of Livin in cells resulted in protection from apoptosis induced by FADD, BAX, RIP, RIP3 and DR6 (1). Livin has direct interaction with several caspases including caspase-3, -7, and -9. Livin inhibits the activation of caspase-9 induced by Apaf-1, cytochrome c, and dATP. The two isoforms of Livin appear to have different functions and tissue distributions.|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of Livin expression in human Raji cell lysate with Livin antibody at 0.5 ug/ml.
Immunohistochemistry of Livin in human small intestine tissue with Livin antibody at 5 ug/ml.